help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on September 15, 2005, doi:10.1164/rccm.200504-595OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200504-595OCv1
172/12/1510    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stevenson, N. J.
Right arrow Articles by Calverley, P. M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stevenson, N. J.
Right arrow Articles by Calverley, P. M. A.
American Journal of Respiratory and Critical Care Medicine Vol 172. pp. 1510-1516, (2005)
© 2005 American Thoracic Society
doi: 10.1164/rccm.200504-595OC


Original Article

Lung Mechanics and Dyspnea during Exacerbations of Chronic Obstructive Pulmonary Disease

Nicola J. Stevenson, Paul P. Walker, Richard W. Costello and Peter M. A. Calverley

Department of Medicine, Clinical Sciences Centre, University Hospital Aintree, Liverpool, United Kingdom; and Department of Medicine, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland

Correspondence and requests for reprints should be addressed to Peter Calverley, M.D., F.R.C.P., Department of Medicine, Clinical Sciences Centre, University Hospital Aintree, Longmoor Lane, Liverpool L9 7AL, UK. E-mail: pmacal{at}liverpool.ac.uk

Rationale: Exacerbation of chronic obstructive pulmonary disease commonly causes hospitalization. The change in lung mechanics during exacerbation and its relationship to symptoms in spontaneously breathing individuals has not been described.

Objective: We hypothesized that changes in both airflow and lung volumes would occur during an exacerbation, but that only volume change would relate to symptomatic improvement.

Methods: Lung mechanics and resting dyspnea were recorded in 22 hospitalized patients during recovery from exacerbation.

Measurements: Spirometry, inspiratory capacity, respiratory system resistance and reactance, tidal breathing patterns, and expiratory flow limitation were recorded after nebulized bronchodilator therapy on the first 3 d after admission, at discharge, and 6 wk postadmission (Day 42). Prebronchodilator measurements were taken on Day 2, at discharge, and on Day 42.

Main Results: Postbronchodilator inspiratory capacity increased 0.23 ± 0.07 L by discharge and 0.42 ± 0.1 L by Day 42, FEV1 rose 0.09 ± 0.04 and 0.2 ± 0.05 L at discharge and Day 42, respectively, and FVC increased 0.21 ± 0.08 and 0.47 ± 0.09 L at discharge and Day 42 (all p < 0.05). Consistent reduction in dyspnea was seen as the exacerbation resolved. Respiratory system resistance, FEV1/FVC, and expiratory flow limitation were unchanged throughout, indicating that changes in lung volume rather than airflow resistance predominated.

Conclusions: Improvement in operating lung volumes is the principal change seen as a chronic obstructive pulmonary disease exacerbation resolves and increase in inspiratory capacity is a useful guide to a reduction in dyspnea.

Key Words: breathlessness • inspiratory reserve volume • lung function • lung hyperinflation




This article has been cited by other articles:


Home page
Eur Respir JHome page
P. Albert and P. M. A. Calverley
Drugs (including oxygen) in severe COPD
Eur. Respir. J., May 1, 2008; 31(5): 1114 - 1124.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. Calverley
Understanding Breathlessness in Mild Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., March 15, 2008; 177(6): 564 - 565.
[Full Text] [PDF]


Home page
Eur Respir JHome page
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al.
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Eur. Respir. J., February 1, 2008; 31(2): 416 - 469.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
F. J. Martinez
Pathogen-directed Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, December 1, 2007; 4(8): 647 - 658.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. Polverino, F. P. Gomez, H. Manrique, N. Soler, J. Roca, J. A. Barbera, and R. Rodriguez-Roisin
Gas Exchange Response to Short-Acting beta2-Agonists in Chronic Obstructive Pulmonary Disease Severe Exacerbations
Am. J. Respir. Crit. Care Med., August 15, 2007; 176(4): 350 - 355.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
B. R. Celli and P. J. Barnes
Exacerbations of chronic obstructive pulmonary disease
Eur. Respir. J., June 1, 2007; 29(6): 1224 - 1238.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
H. Gunen, S. S. Hacievliyagil, O. Yetkin, G. Gulbas, L. C. Mutlu, and E. In
The role of nebulised budesonide in the treatment of exacerbations of COPD
Eur. Respir. J., April 1, 2007; 29(4): 660 - 667.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
M. K Johnson, M. Birch, R. Carter, J. Kinsella, and R. D Stevenson
Measurement of physiological recovery from exacerbation of chronic obstructive pulmonary disease using within-breath forced oscillometry
Thorax, April 1, 2007; 62(4): 299 - 306.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. Kardos, M. Wencker, T. Glaab, and C. Vogelmeier
Impact of Salmeterol/Fluticasone Propionate versus Salmeterol on Exacerbations in Severe Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 144 - 149.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
V. M. Pinto-Plata, G. Livnat, M. Girish, H. Cabral, P. Masdin, P. Linacre, R. Dew, L. Kenney, and B. R. Celli
Systemic Cytokines, Clinical and Physiological Changes in Patients Hospitalized for Exacerbation of COPD
Chest, January 1, 2007; 131(1): 37 - 43.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
D. E. O'Donnell and P. Laveneziana
Physiology and consequences of lung hyperinflation in COPD
Eur. Respir. Rev., December 1, 2006; 15(100): 61 - 67.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
P. M. A. Calverley
Exercise and dyspnoea in COPD
Eur. Respir. Rev., December 1, 2006; 15(100): 72 - 79.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
R Rodriguez-Roisin
COPD exacerbations {middle dot} 5: Management.
Thorax, June 1, 2006; 61(6): 535 - 544.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Update in chronic obstructive pulmonary disease 2005.
Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1056 - 1065.
[Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
J. A. Wedzicha and T. Wilkinson
Impact of Chronic Obstructive Pulmonary Disease Exacerbations on Patients and Payers
Proceedings of the ATS, May 1, 2006; 3(3): 218 - 221.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
A. Papi, F. Luppi, F. Franco, and L. M. Fabbri
Pathophysiology of Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, May 1, 2006; 3(3): 245 - 251.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
S Scott, P Walker, and P M A Calverley
COPD exacerbations {middle dot} 4: Prevention
Thorax, May 1, 2006; 61(5): 440 - 447.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
D E O'Donnell and C M Parker
COPD exacerbations {middle dot} 3: Pathophysiology.
Thorax, April 1, 2006; 61(4): 354 - 361.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society
  Solid Organ Transplant for the Intensivist 2008